RxCelerate Inc

RxCelerate is as an outsourced drug development platform specialising in bespoke experimental design with data-rich end-points.

[RxCelerate Inc @RxCelerateUS]

Congrats to David - new CIO at Centessa. Good hands at the wheel.
https://t.co/FGnVCtRts9

[RxCelerate Inc @RxCelerateUS]

Great discussion here from Grant with Jill and Jon at RxCelerate.

[The Bioinformatics CRO @BioinfoCRO]

Virtual biotech companies are small, nimble & efficient. Jill Reckless and Jon Heal discuss how outsourced drug development platforms like @RxCelerate can help these companies take therapeutics to market.
https://t.co/DnQfbzoG8L

[RxCelerate Inc @RxCelerateUS]

Well done to all!

[Magdalene Boat Club @MagdBoatClub]

MAGDALENE at HENLEY 2021
In the week gone by, Magdalene has made history at Henley Royal Regatta.
A summary from both the men’s and women’s side can be viewed on the MBC Facebook page. https://t.co/VIABbRu0tA
Many thanks to everyone who made this campaign possible.
@RxCelerate

[RxCelerate @RxCelerate]

Busy week at @rxcelerate

* Launch of our investment vehicle RxCapital https://t.co/nzDod1Widw

* public debut of our portfolio co @RivusPharma in the clinic with HU6 to treat metabolic diseases https://t.co/oZLKsqjuFY

* #TeamRxCelerate continues to grow https://t.co/nQvqC3W1Nf

[RxCelerate @RxCelerate]

Great thread from our Chairman explaining why we are so excited to invest alongside @medicxi & Longitude in the @RivusPharma Series A

[RxCelerate Inc @RxCelerateUS]

Well done team! Very much looking forward to the process and potential for clinical impact.

[RxCelerate @RxCelerate]

We have been so excited to announce this week the launch of RxCaptal, our venture capital fund investing in cutting-edge drug discovery & development

https://t.co/2s0jXUDauY

[RxCelerate Inc @RxCelerateUS]

Congrats to David Grainger, (@sciencescanner) RxCelerate, Ltd. Chairman, and the Rivus Pharma team: https://t.co/nyezxaEgCe

[RxCelerate @RxCelerate]

Some exciting news breaking tomorrow! Watch this space…

[RxCelerate Inc @RxCelerateUS]

RxCelerate US would like to express condolences to our RxCelerate UK team on the result of the match yesterday. Well played, a tremendous journey for the side, and it was a thrill watching.

[RxCelerate Inc @RxCelerateUS]

We would get excited about this too . . .

[RxCelerate Inc @RxCelerateUS]

Again, great opportunity here to work on clinically-oriented programs. Do reach out.

[RxBiologics Limited @rxbiologics]

Demand for our Galaxy platform has been stellar (excuse the pun!) - so we are growing

We are looking for a PhD level Scientist / Senior Scientist with experience in antibody engineering: https://t.co/iKxbDo4bBy

And a Team Leader with 5+ yrs experience: https://t.co/26dGpbTYrk

[RxCelerate Inc @RxCelerateUS]

Great group here with Jonny Finlay. Diverse and impactful projects for those interested in delivering meaningful medicines.

[RxCelerate @RxCelerate]

Opportunities for experienced antibody engineers to join #TeamRxCelerate

[RxCelerate Inc @RxCelerateUS]

. . . and increasingly on either side of the Atlantic.

[RxCelerate @RxCelerate]

Wish you had access to the kind of discovery technology used by big pharma co’s?

Imagine you could do better if you had access to those capabilities?

Stop imagining - you already do! Our world-class small & large molecule discovery services are available to anyone with an idea

[RxCelerate Inc @RxCelerateUS]

Very cool . . .

[RxCelerate @RxCelerate]

Just seen the first output from “Project Emporer” - @RxInsilico’s new #AI powered binding classifier - presented to a client. Impressive gain in predictive power when applied to previous activity assay data

Looking forward to seeing it on other projects

[RxBiologics Limited @rxbiologics]

No more licensing other people’s technology to make a bispecific

Optimum manufacturability (equal to the parental monospecifics)

No increase in ADA risk

With Galaxy, bispecific antibody drugs are as easy, quick & cheap to find as “old-fashioned” monoclonals

[RxBiologics Limited @rxbiologics]

One of the biggest advantages of our Galaxy antibody discovery platform isn’t immediately obvious:

The way we control light chain diversity ensures that pairs of clones selected in parallel can be combined into native bispecifics

[RxCelerate Inc @RxCelerateUS]

Thanks @rxbiologics team!

[RxBiologics Limited @rxbiologics]

By the way, you can also now find us at https://t.co/EdMaJ4vppF which may be easier to remember for our US clients

@RxCelerateUS

[RxCelerate Inc @RxCelerateUS]

Looking forward to this:

[RxBiologics Limited @rxbiologics]

It’s easy to forget that other people don’t always “get” what’s special about the technology you spend day & night thinking about...

Recently, talking to a potential client for Galaxy, we were trying to explain how dynamic evolution makes our antibody discovery platform special

[RxCelerate @RxCelerate]

Congratulations Chris! Fantastic news

If @RxCelerate can help any of the new start-ups, you know where to find us